A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
A Multi-Step Approach for Accurate & Timely Data
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register TodayMarket Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
Aurinia Pharmaceuticals’ initiation of its Phase II/III AUDREY trial in dry eye keeps Aurinia in the middle of the pack of companies racing to develop the next pharmaceutical treatment for dry eye ...
Johnson and Johnson Vision announced Dec. 4 that industry veteran Tom Frinzi was retiring from his role as worldwide president of surgical vision. Warren Faust officially stepped into the role Dec....
Beaver-Visitec International (BVI), of Waltham, Massachusetts, announced Dec. 6 that it had acquired Arcadophta—also known as Arcad, an ophthalmic company specializing in silicon oils, gases, and p...
The National Eye Hospital in Paris and French company GenSight Biologics announced Dec. 9 that that the French Competent Authority granted a patient Temporary Authorization for Use for Lumevoq, Gen...
Regeneron, of Tarrytown, New York, has announced that the Eylea (aflibercept) prefilled syringe is now available for doctors to order. The 2 mg, single-dose, sterilized prefilled syringe requires f...
Aurinia Pharmaceuticals, focused on advancing voclosporin in multiple indications, including dry eye, announced Dec. 12 that it had raised $191.7 million, before expenses, in an underwritten public...
Limelight Bio announced Dec. 5 that it had raised $75 million in new financing funded by Apple Tree Partners (ATP), a leading life sciences innovation fund. Limelight Bio, with operations in Philad...
Omeros announced Dec. 13 the full exercise and closing of the sale of 572,518 shares of common stock to the underwriter of its previously announced public offering. When combined with shares sold i...
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.